PURPOSE To examine cardiovascular disease (CVD) and mortality risk in women with
breast cancer (BC) by cancer therapy received relative to women without BC. METHODS …

PURPOSE The incidence of cardiometabolic risk factors in breast cancer (BC) survivors has
not been well described. Thus, we compared risk of hypertension, diabetes, and …

Purpose Breast cancer incidence and survival is high, which results in high prevalence of
breast cancer survivors. The risk of (death from) cardiovascular disease (CVD) is higher in …

Objectives This study evaluates the risk of cardiovascular disease (CVD) following breast
cancer, accounting for baseline CVD risk. Methods Within the EPIC-NL (Dutch part of the …

Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many
people perceive breast cancer to be the number one threat to women's health. CVD and …

Background Clinical trials demonstrated that women treated for breast cancer with
anthracycline or trastuzumab are at increased risk for heart failure and/or cardiomyopathy …

Purpose Most women diagnosed with breast cancer are younger than 65 years of age.
Population-based studies on cancer therapy–related cardiotoxicity have focused on older …

Importance There is increasing interest in the effect of cardiovascular disease on cancer
survivors. However, there are limited contemporary population-based data on the risk of …

Background Cardiovascular disease is the primary cause of death among patients with
breast cancer. However, the association of cardiovascular-disease risk factors (CVD-RFs) …

Background: Cardiovascular disease (CVD) is of increasing concern among breast cancer
survivors. However, the burden of this comorbidity in this group relative to the general …